Your browser doesn't support javascript.
loading
The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation.
Bolek, Tomás; Samos, Matej; Stanciaková, Lucia; Skornová, Ingrid; Grilusová, Kristína; Galajda, Peter; Stasko, Ján; Kubisz, Peter; Mokán, Marián.
Afiliação
  • Bolek T; Department of Internal Medicine I.
  • Samos M; Department of Internal Medicine I.
  • Stanciaková L; National Centre of Hemostasis and Thrombosis, Department of Hematology and Blood Transfusion, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.
  • Skornová I; National Centre of Hemostasis and Thrombosis, Department of Hematology and Blood Transfusion, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.
  • Grilusová K; Department of Internal Medicine I.
  • Galajda P; Department of Internal Medicine I.
  • Stasko J; National Centre of Hemostasis and Thrombosis, Department of Hematology and Blood Transfusion, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.
  • Kubisz P; National Centre of Hemostasis and Thrombosis, Department of Hematology and Blood Transfusion, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.
  • Mokán M; Department of Internal Medicine I.
Blood Coagul Fibrinolysis ; 32(1): 69-71, 2021 01 01.
Article em En | MEDLINE | ID: mdl-33122496

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Antitrombinas / Atorvastatina / Dabigatrana / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Antitrombinas / Atorvastatina / Dabigatrana / Anticolesterolemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article